TIROSINT-SOL FDA approval date

The FDA approved TIROSINT-SOL on 15 Dec 2016.

FDA approval date
15 Dec 2016

Drug identity has not yet been verified against registry records

Also recorded as LEVOTHYROXINE SODIUM

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2016-12-15DayTIROSINT-SOLFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA206977", "applicant_as_listed_by_fda": "IBSA", "brand_names": ["TIROSINT-SOL"], "active_ingredients": ["LEVOTHYROXINE SODIUM"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20161215", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026